Erratum: Ischemic stroke is associated with the ABO locus: The EuroCLOT study

Errata

This article corrects:

  1. Ischemic stroke is associated with the ABO locus: The EuroCLOT study Volume 73, Issue 1, 16–31, Article first published online: January 2013

Affiliations were incorrectly attributed to some authors in the article “Ischemic Stroke Is Associated with the ABO Locus: The EuroCLOT Study” by Williams et al. The correct author list and affiliations are, as follows

Frances M. K. Williams, PhD, FRCP(E),1 Angela M. Carter, PhD,2 Pirro G. Hysi, PhD,1 Gabriela Surdulescu, MSc,1 Dylan Hodgkiss, MSc,1 Nicole Soranzo, PhD,3,4,5 Matthew Traylor, MSc,6 Steve Bevan, PhD,6 Martin Dichgans, MD, PhD,7 Peter M. W. Rothwell, MD, PhD, FMedSci,8 Cathie Sudlow, DPhil, FRCP(E),9 Martin Farrall, PhD, FRCPath,10 Kaisa Silander, PhD,11 Mari Kaunisto, PhD,11 Peter Wagner, BSc,11 Olli Saarela, PhD,12 Kari Kuulasmaa, PhD,12 Jarmo Virtamo, MD, PhD,12 Veikko Salomaa, MD, PhD,12 Philippe Amouyel, MD, PhD,13 Dominique Arveiler, MD,14 Jean Ferrieres, MD,15 Per-Gunnar Wiklund, MD, PhD,16 M. Arfan Ikram, MD, PhD,17 Albert Hofman, MD, PhD,17 Giorgio B. Boncoraglio, MD,18 Eugenio A. Parati, MD,18 Anna Helgadottir, MD, PhD,10,19 Solveig Gretarsdottir, PhD,19 Unnur Thorsteinsdottir, PhD,19 Gudmar Thorleifsson, PhD,19 Kari Stefansson, PhD, Dr Med,19 Sudha Seshadri, MD,20,21 Anita DeStefano, PhD,20,21 Andreas Gschwendtner, Dr MED,7 Bruce Psaty, MD, PhD,22,23,24,25 Will Longstreth, MD,22,23,26 Braxton D. Mitchell, MPH, PhD,27 Yu-Ching Cheng, PhD,27 Robert Clarke, MD,28 Marco Ferrario, MD,29 Joshua C. Bis, PhD,30 Christopher Levi, BSc, MBBS,31,32,33 John Attia, MD, PhD,31,32,33 Elizabeth G. Holliday, PhD,31,32,33 Rodney J. Scott, PhD, FRCPath,31,32,33 Myriam Fornage, PhD,34 Pankaj Sharma, PhD, FRCP,35 Karen L. Furie, MD,36 Jonathan Rosand, MD, MSc,36 Mike Nalls, PhD,37 James Meschia, MD,37 Thomas H. Mosely, PhD,38 Alun Evans, MD,39 Aarno Palotie, MD, PhD,3,4,5,11 Hugh S. Markus, MD, FRCP,6 Peter J. Grant, MD, FRCP,2 Tim D. Spector, MD, FRCP,1 on Behalf of the EuroCLOT Investigators, the Wellcome Trust Case Control Consortium 2, MOnica Risk, Genetics, Archiving and Monograph, MetaStroke, the International Stroke Genetics Consortium

1Department of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom; 2Division of Cardiovascular and Diabetes Research, University of Leeds, Leeds, United Kingdom; 3Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom; 4Program in Medical and Population Genetics and Genetic Analysis Platform, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA; 5Department of Medical Genetics, University of Helsinki and University Central Hospital, Helsinki, Finland; 6Stroke and Dementia Research Centre, St George's University of London, London, United Kingdom; 7Institute for Stroke and Dementia Research, Klinikum der Universität Munich, Ludwig-Maximilians-University, Munich, Germany; 8Stroke Prevention Research Unit, University Department of Clinical Neurology, Oxford University, Oxford, United Kingdom; 9Division of Clinical Neurosciences, University of Edinburgh, Edinburgh, United Kingdom; 10Wellcome Trust Centre for Human Genetics and Department of Cardiovascular Medicine, University of Oxford, Oxford, United Kingdom; 11Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland; 12Chronic Disease Epidemiology and Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland; 13Department of Epidemiology and Public Health, Pasteur Institute of Lille, Lille, France; 14Department of Epidemiology and Public Health, University of Strasbourg, Strasbourg, France; 15Department of Epidemiology, Faculty of Medicine, Toulouse-Purpan, Toulouse, France; 16Department of Internal Medicine, University of Umeå, Umeå, Sweden; 17Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands; 18Department of Neurology, Research Hospital of the Neurological Institute “Carlo Besta,” Milan, Italy; 19DeCODE Genetics, Reykjavik, Iceland; 20Boston University Schools of Medicine and Public Health, Boston, MA; 21Framingham Heart Study, Framingham, MA; 22Departments of Health Services, University of Washington, Seattle, WA; 23Epidemiology, Health Services, University of Washington, Seattle, WA; 24Medicine, and Health Services, University of Washington, Seattle, WA; 25Group Health Research Institute, Group Health, Seattle, WA; 26Department of Neurology, University of Washington, WA; 27Department of Medicine, University of Maryland, Baltimore, MD; 28Clinical Trial Service Unit, University of Oxford, Oxford, United Kingdom; 29Reseach Center in Epidemiology and Preventive Medicine, University of Insubria, Varese, Italy; 30Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA; 31University of Newcastle, Callaghan, Australia; 32John Hunter Hospital, New Lambton Heights, Australia; 33Hunter Medical Research Institute, New Lambton, Australia; 34Human Genetics Center and Institute of Molecular Medicine, University of Texas Health Sciences Center, Houston, TX; 35Imperial College Cerebrovascular Research Unit, Imperial College London, London, United Kingdom; 36Center for Human Genetic Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA; 37Department of Neurology, Mayo Clinic, Jacksonville, FL, USA; 38University of Mississippi Medical Center, Jackson, MS; 39Queen's University of Belfast, Belfast, United Kingdom

Ancillary